Advaxis Appoints Gregory T. Mayes as Chief Operating Officer

29-10-2013 Business Wire HealthComments (0)


Advaxis, Inc., (NASDAQ:ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has appointed Gregory T. Mayes to the new position of Executive Vice President and Chief Operating Officer. Mr. Mayes joins Advaxis following the recent closing of a financing totaling $26.5 million and an uplisting to the NASDAQ Capital Market. Advaxis is now positioned to maximize the potential of its proprietary im

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top